Analysis of effects of PI3K inhibitor of tumor immune microenvironment
K14-PIK3CA GEMMs treated with 4-NQO for 16 weeks to induce oral cavity tumors were then treated with Pictilisib or Vehicle control and subjected to 10x scRNA sequencing.